Cancer-associated retinopathy in a 66 years-old woman with small-cell lung cancer

Mathilde Jeanvoine (Rouen, France), Mathilde Jeanvoine, Mathieu Salaün, Florian Guisier, Julie Gueudry, Suzanna Bota, Luc Thiberville

Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Session: Thoracic oncology around the world: rare cases and local features
Session type: Thematic Poster Session
Number: 4304
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Mathilde Jeanvoine (Rouen, France), Mathilde Jeanvoine, Mathieu Salaün, Florian Guisier, Julie Gueudry, Suzanna Bota, Luc Thiberville. Cancer-associated retinopathy in a 66 years-old woman with small-cell lung cancer. Eur Respir J 2015; 46: Suppl. 59, 4304

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Multiple primary malignancies in Japanese patients with non-small cell lung cancer
Source: Annual Congress 2013 –Epidemiology of respiratory disease
Year: 2013

Surgical treatmment non-small cell lung cancer in the elderly patients
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015

Major changes in men with non-small-cell lung cancer (NSCLC) in 10 years: The KBP-2000-CPHG and KBP-2010-CPHG cohorts
Source: Annual Congress 2013 –Epidemiology, screening and diagnosis of lung cancer
Year: 2013



Chemotherapy in elderly patients with non-small-cell lung cancer in Tunisian respiratory department
Source: Annual Congress 2013 –Systemic therapy of lung cancer and quality of life
Year: 2013


Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014


Mortality in asymptomatic vs. symptomatic patients surgically treated for non-small cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts
Year: 2013


Checkpointinhibition in lung cancer – How to distinguish pseudoprogression from progressive disease
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Screening for intracerebral metastasis in radically treated non-small cell lung cancer patients
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016


Prognostic factors in non-small cell lung cancer
Source: International Congress 2015 – Diagnosis and therapy of lung cancer
Year: 2015


Second primary lung cancer in squamous NSCLC patients: The Nancy Biobank's database
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014

Prognostic impact of secondary malignancies in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015

The prognostic significance of thrombocytopenia during chemotherapy in patients with advanced non-small cell lung cancer
Source: International Congress 2016 – Basic science and case reports in lung cancer
Year: 2016

Adrenalectomy for isolated lesions in operable patients with non-small-cell lung cancer
Source: International Congress 2016 – Special issues in thoracic surgery
Year: 2016

Expression analysis of miR-21 in Bulgarian patients with non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016


Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014

Evaluation of predictive and therapeutic value of WSX1/IL27 axis in non-small cell lung cancer (NSCLC)
Source: International Congress 2015 – Cell biology of lung cancer and new biomarkers
Year: 2015

Progression vs. pseudo progression in the treatment of squamous NSCLC with nivolumab
Source: International Congress 2016 – Lung cancer: therapeutic modalities, re-staging, and follow-up
Year: 2016

Methilation status in EBUS-NA samples of lung cancer
Source: International Congress 2014 – Improving diagnosis of thoracic tumours
Year: 2014

A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014



Survival of non small cell lung carcinoma patients with malignant pleural effusions
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014